Pharmaids Pharmaceuticals
Pharmaids Pharmaceuticals Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Pharmaids Pharmaceuticals
Start SIPPharmaids Pharmaceuticals Investment Rating
-
Master Rating:
-
Pharmaids Pharms. has an operating revenue of Rs. 0.30 Cr. on a trailing 12-month basis. Pre-tax margin of 0% needs improvement, ROE of -33% is poor and needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 62% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 3 which is a POOR score indicating inconsistency in earnings, a RS Rating of 83 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 111 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of D is close to being the worst. Overall, the stock has some relative strength and buyer demand but we want to see further fundamental performance to qualify as a growth stock.
EPS Strength
Price Strength
Buyer Demand
Group Rank
Indicator | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
---|---|---|---|---|---|---|
Oper Rev Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Expenses Qtr Cr | 2 | 9 | 1 | 1 | 0 | 0 |
Operating Profit Qtr Cr | -2 | -9 | -1 | -1 | 0 | 0 |
Depreciation Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 |
Interest Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Qtr Cr | 0 | -2 | 0 | 0 | 0 | 0 |
Net Profit Qtr Cr | -1 | -6 | -1 | -1 | 0 | 0 |
Pharmaids Pharmaceuticals Technicals
EMA & SMA

- Bullish Moving Average
- ___
- 14
- Bearish Moving Average
- ___
- 2
- 20 Day
- ₹38.43
- 50 Day
- ₹37.3
- 100 Day
- ₹33.62
- 200 Day
- ₹27.71
- 20 Day
- ₹38.18
- 50 Day
- ₹38.41
- 100 Day
- ₹34.41
- 200 Day
- ₹24.24
Pharmaids Pharmaceuticals Resistance and Support
Resistance | |
---|---|
First Resistance | ₹39.33 |
Second Resistance | ₹39.66 |
Third Resistance | ₹40.11 |
RSI | 53.44 |
MFI | 54.68 |
MACD Single Line | 0.23 |
MACD | 0.45 |
Support | |
---|---|
First Resistance | ₹38.55 |
Second Resistance | ₹38.1 |
Third Resistance | ₹37.77 |
Pharmaids Pharmaceuticals Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 2,675 | 267,500 | 100 |
Week | 13,043 | 1,304,300 | 100 |
1 Month | 9,808 | 980,786 | 100 |
6 Month | 8,261 | 826,132 | 100 |
Pharmaids Pharmaceuticals Result Highlights
Pharmaids Pharmaceuticals Synopsis
BSE-Medical-Diversified
Pharmaids Pharma belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 0.00 Cr. and Equity Capital is Rs. 21.44 Cr. for the Year ended 31/03/2023. Pharmaids Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 01/03/1989 and has its registered office in the State of Karnataka, India. Company’s Corporate Identification Number(CIN) is L52520KA1989PLC173979 and registration number is 173979.Market Cap | 84 |
Sales | |
Shares in Float | 1.93 |
No of funds | |
Yield |
Book Value | 3.73 |
U/D Vol ratio | 0.7 |
LTDebt / Equity | |
Alpha | 0.79 |
Beta | 0.63 |
Pharmaids Pharmaceuticals
Owner Name | Jun-23 | Mar-23 | Jan-23 | Dec-22 |
---|---|---|---|---|
Promoters | 9.94% | 9.95% | 16.45% | 16.54% |
Individual Investors | 81.28% | 81.71% | 69.87% | 69.78% |
Others | 8.78% | 8.34% | 13.68% | 13.68% |
Pharmaids Pharmaceuticals Management
Name | Designation |
---|---|
Mr. Venu Madhava Kaparthy | Executive Director |
Ms. Mini Manikantan | Executive Director |
Mr. Venkata Rao Sadhanala | Non Exe.Non Ind.Director |
Mr. Mopperthy Sudheer | Independent Director |
Mr. Methuku Nagesh | Independent Director |
Mr. P N Vijay | Independent Director |
Pharmaids Pharmaceuticals Forecast
Price Estimates
Pharmaids Pharmaceuticals Corporate Action
Date | Purpose | Remarks |
---|---|---|
2023-08-04 | Quarterly Results | |
2023-05-29 | Audited Results | |
2023-02-13 | Quarterly Results | |
2023-01-17 | Others | |
2022-12-06 | Others | Rs.0.00 to consider Preferential issue of 84,00,000 equity shares of Rs. 10/- each in accordance with applicable provisions and subject to necessary approvals.. |
- Company Name
- CMP
- Chg(%)
- Hindalco Inds.
- 493
- 5.5
- NTPC
- 246
- 3.6
- Hero Motocorp
- 3057
- 2.9
- Dr Reddys Labs
- 5587
- 2.9
- Divis Lab.
- 3765
- 2.7
- Company Name
- CMP
- Chg(%)
- Adani Enterp.
- 2414
- -2.5
- LTIMindtree
- 5210
- -1.0
- HCL Technologies
- 1235
- -0.6
- Tech Mahindra
- 1223
- -0.5
- Power Grid Corpn
- 200
- -0.5
Pharmaids Pharmaceuticals FAQs
What is Share Price of Pharmaids Pharmaceuticals ?
Pharmaids Pharmaceuticals share price is ₹39 As on 30 September, 2023 | 05:58
What is the Market Cap of Pharmaids Pharmaceuticals ?
The Market Cap of Pharmaids Pharmaceuticals is ₹83.8 Cr As on 30 September, 2023 | 05:58
What is the P/E ratio of Pharmaids Pharmaceuticals ?
The P/E ratio of Pharmaids Pharmaceuticals is -9.6 As on 30 September, 2023 | 05:58
What is the PB ratio of Pharmaids Pharmaceuticals ?
The PB ratio of Pharmaids Pharmaceuticals is 3.7 As on 30 September, 2023 | 05:58